NASDAQ:ICCC
ImmuCell Corporation Stock News
$4.91
-0.190 (-3.73%)
At Close: Apr 30, 2024
Critical Review: Global WholeHealth Partners (OTCMKTS:GWHP) and ImmuCell (NASDAQ:ICCC)
02:14am, Wednesday, 15'th Dec 2021 Transcript Daily
Global WholeHealth Partners (OTCMKTS:GWHP) and ImmuCell (NASDAQ:ICCC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Valuation & Earnings This table compares Global WholeHealth Partners and ImmuCells gross revenue, earnings per []
In brief: Santos submits application for Oil Search merger to ICCC and other business stories
03:29am, Wednesday, 17'th Nov 2021 Business Advantage PNG
Santos and Oil Search merger now in the hands of the ICCC, DataCo reduces wholesale prices by 66 per cent for metro fibre connectivity services, and Treasurer Ling-Stuckey receives report on the Central Bank Act 2000 review. The business news you need to know. The post In brief: Santos submits application for Oil Search merger to ICCC and other business stories appeared first on Business Advantage PNG .
ImmuCell Corp (ICCC) CEO Michael Brigham on Q3 2021 Results - Earnings Call Transcript
07:22pm, Tuesday, 16'th Nov 2021 Seeking AlphaImmuCell Corp (ICCC) CEO Michael Brigham on Q3 2021 Results - Earnings Call Transcript
02:22pm, Tuesday, 16'th Nov 2021
ImmuCell Corp (ICCC) CEO Michael Brigham on Q3 2021 Results - Earnings Call Transcript
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021
09:05pm, Monday, 15'th Nov 2021 GlobeNewswire Inc.
Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000) Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000)
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021
09:05pm, Monday, 15'th Nov 2021 Intrado Digital Media
Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000) Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000)
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
02:57pm, Sunday, 14'th Nov 2021 Benzinga
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
Among the
ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021
06:30am, Wednesday, 06'th Oct 2021
PORTLAND, Maine, Oct. 06, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
Raffael Lichdi, DVM Joins ImmuCell's Sales & Marketing Team
06:30am, Tuesday, 14'th Sep 2021
PORTLAND, Maine, Sept. 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC
06:42pm, Thursday, 02'nd Sep 2021
New York, New York--(Newsfile Corp. - September 2, 2021) - Pomerantz LLP is investigating claims on behalf of investors of ImmuCell Corporation ("ImmuCell" or the "Company") (NASDAQ: ICCC). Such inves
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC
07:18pm, Wednesday, 25'th Aug 2021
New York, New York--(Newsfile Corp. - August 25, 2021) - Pomerantz LLP is investigating claims on behalf of investors of ImmuCell Corporation ("ImmuCell" or the "Company") (NASDAQ: ICCC). Such inves
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC
07:29pm, Tuesday, 24'th Aug 2021
NEW YORK, Aug. 24, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ImmuCell Corporation ("ImmuCell" or the "Company") (NASDAQ: ICCC). Such investors are ad
ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®
06:30am, Tuesday, 24'th Aug 2021
PORTLAND, Maine, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2021 Results - Earnings Call Transcript
11:45am, Friday, 13'th Aug 2021
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2021 Results - Earnings Call Transcript